Company name: NeuWave Medical Inc.
Industry: Medical devices.
Location: Madison, Wisconsin.
Solution/product: Certus 140 Ablation System is a device that uses energy to coagulate and ablate soft tissue.
Money raised: $14 million (seeking another $5 million).
How it will be used: President and CEO Laura King did not immediately return a call.
Investors: Venture Investors LLC; John Murphy, president and CEO of NDS Surgical.
Management team: Laura King, president and CEO; Rick Schefelker, vice president of engineering; Eric Clyse, vice president of operations.
Market size: The global ablation technologies market is expected to reach $12.4 billion by 2016.
Competitors: Larger players like Medtronic and Boston Scientific have acquired ablation technology startups; BSD Medical.
[Photo Credit: freedigitalphotos.net user Salvatore Vuono]
Reserve your seat now for MedCity CONVERGE, to be held July 9-10 in Philadelphia. Discover strategies, solutions and startups in healthcare innovation. Be a part of this gathering where the entire healthcare ecosystem converges.
By Arundhati Parmar
Arundhati Parmar is the Medical Devices Reporter at MedCity News. She has covered medical technology since 2008 and specialized in business journalism since 2001. Parmar has three degrees from three continents - a Bachelor of Arts in English from Jadavpur University, Kolkata, India; a Masters in English Literature from the University of Sydney, Australia and a Masters in Journalism from Northwestern University in Chicago. She has sworn never to enter a classroom again.More posts by Author
- Get Livefyre
- FAQ
